SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?


To: Aishwarya who wrote (693)5/5/1998 9:37:00 PM
From: Jeffrey L. Henken  Read Replies (1) | Respond to of 2887
 
Competitive advantages of American BioMed's Catheter line:

1.) First and foremost American BioMed's catheters are made of 100% silicone which means they will never cause anyone to die from anaphylatic shock as has happened with patients allergic to latex.

2.) Second they are made using a patented dipping technology that makes the balloon an integral part of the catheter. It does not have to be attached by glues or sutures.

3.) Third because these catheters are silicone and not latex or PVC they have a longer shelve life and are resistant to breakdown from sunlight.

4.) The balloon portion of the catheter is symmetrical rather than the asymmetrical design of the company's competitors.

5.) The catheters are non-fragmenting. This means if the balloon is over expanded it will not break into pieces like a latex catheter.

6.) There are a few other silicone catheters manufactured by competitors. Most are merely latex coated with silicone. But no one has the full 100% silicone catheter product line that American BioMed has developed. Expect 4 more versions of the company's bilumen catheter to be approved soon by the FDA.

I don't think it will be too long before the stock market in general becomes aware of just how competitive these catheters really are!

Up another 10% today. Gee maybe the market knows something TokyoMex does not!

GO ABMI!


Regards, Jeff